A 29-year-old woman was referred to Tufts Medical Center for undifferentiated bilateral anterior and intermediate uveitis.The ...
Hosted on MSN
Early detection is key to improving treatment of uveitis, a global leading cause of vision loss
New treatment guidance has been developed to help doctors tackle uveitis—one of the leading causes of vision loss. The new clinical guidance, by a team at the University of Bristol, aims to help ...
Patients with psoriasis, uveitis, or colitis who present with undiagnosed chronic back pain should be referred to a rheumatologist for the assessment of axial spondyloarthritis (axSpA), with MRI being ...
Significantly fewer patients in the fluocinolone acetonide intravitreal implant group experienced recurrence of uveitis at 6 months compared with the sham group. The Food and Drug Administration (FDA) ...
The MarketWatch News Department was not involved in the creation of this content. Vyome's offering is a first-of-its-kind in a broader $20B potential addressable ocular inflammation market VT-1908 ...
2025 MAR 28 (NewsRx) -- By a News Reporter-Staff News Editor at Information Technology Business Daily-- New research on Eye Diseases and Conditions - Anterior Uveitis is the subject of a report.
Non-infectious uveitis is a rare immune-mediated condition in children and is often treated with the tumor necrosis factor inhibitor adalimumab. Discontinuing the drug may be considered when remission ...
Vyome Presents Strong Data Showing Topical VT-1908 is an Effective Treatment for Uveitis, Opening Up a $3B Addressable Market Opportunity Vyome’s offering is a first-of-its-kind in a broader $20B ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback